OverviewChartTechnicalNewsTraderScreen

Celyad Oncology/  BE0974260896  /

Euronext - Brüssel
2024-07-26  5:35:15 PM Chg. -0.0090 Volume Bid5:40:00 PM Ask5:40:00 PM High Low
0.2550EUR -3.41% 1,827
Turnover: 472.2550		 0.2530Bid Size: 7,150 0.2650Ask Size: 10,500 0.2645 0.2540
GlobeNewswire 02-08 Celyad Oncology announces intention to terminate SEC reporting obligations
GlobeNewswire 01-16 Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
GlobeNewswire 2023-12-20 Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §...
GlobeNewswire 2023-12-15 Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
GlobeNewswire 2023-12-04 Celyad announces management change
GlobeNewswire 2023-12-01 Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 M...
GlobeNewswire 2023-11-21 Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §...
GlobeNewswire 2023-11-14 Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
GlobeNewswire 2023-11-09 Celyad Oncology reports third quarter 2023 financial results and recent business highlights
GlobeNewswire 2023-09-25 Celyad Oncology announces the termination of its American Depository Receipt program
GlobeNewswire 2023-09-15 Publication of a rectified transparency notification received from Fortress Investment Group LLC (Ar...
GlobeNewswire 2023-09-12 Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 Ma...
GlobeNewswire 2023-09-07 Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §...
GlobeNewswire 2023-09-05 Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
GlobeNewswire 2023-09-04 Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
GlobeNewswire 2023-08-24 Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical sha...
GlobeNewswire 2022-03-24 Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
GlobeNewswire 2022-03-17 Celyad Oncology to Announce Full Year 2021 Financial Results and Host Conference Call
GlobeNewswire 2022-03-02 Celyad Oncology Announces Clinical Hold of CYAD-101-002 Phase 1b Trial
GlobeNewswire 2022-02-28 Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial
GlobeNewswire 2022-01-31 Celyad Oncology Announces February 2022 Conference Schedule
GlobeNewswire 2022-01-10 Celyad Oncology Provides Outlook for 2022
GlobeNewswire 2021-12-31 Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
GlobeNewswire 2021-12-22 Celyad Oncology Announces January 2022 Conference Schedule
GlobeNewswire 2021-12-17 Transparency notification received from Tolefi SA and related persons (Article 14 §1 of the Law of 2...